CatalystPit

IMCRImmunocore Holdings plc

NASDAQ · Biological Products, (No Diagnostic Substances)
Last close $30.29 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBiological Products, (No Diagnostic Substances)
RECENT INSIDER TRADES
  • 2026-02-19 · Berman David M (HEAD OF R&D) · SELL
  • 2026-02-19 · Jallal Bahija (CHIEF EXECUTIVE OFFICER) · SELL
  • 2026-02-19 · St Leger Tina Amber (CHIEF HR OFFICER) · SELL
  • 2026-02-19 · GOLL JOHN (SVP, FINANCE & CAO) · SELL
  • 2025-12-08 · Berman David M (HEAD OF R&D) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders149
Shares held114,835,440
Value$1.69B
Percent of shares outstanding222.99%
As of quarter end2026-06-30
RECENT NEWS
  • Immunocore: Advanced Cutaneous Melanoma Data Catalysts Feel Crucial
  • Immunocore Holdings presents at Morgan Stanley healthcare conference
  • Immunocore achieves target enrollment in TEBE-AM trial
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Immunocore Holdings plc (IMCR) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit